Halozyme Therapeutics
HALO
#1870
Rank
NZ$19.03 B
Marketcap
NZ$166.99
Share price
-1.82%
Change (1 day)
33.30%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): NZ$1.01 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.66 Billion. In 2025 the company made an earning of NZ$0.85 Billion a decrease over its 2024 earnings that were of NZ$1.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.01 B19.39%
2025 NZ$0.85 B-16.2%
2024 NZ$1.01 B59.94%
2023 NZ$0.63 B39.94%
2022 NZ$0.45 B0.16%
2021 NZ$0.45 B92.2%
2020 NZ$0.23 B-278.96%
2019 -NZ$0.14 Billion-9.45%
2018 -NZ$0.15 Billion-229.51%
2017 NZ$0.11 B-160.48%
2016 -NZ$0.19 Billion216.03%
2015 -NZ$58.92 Million-52.86%
2014 -NZ$0.13 Billion-18.09%
2013 -NZ$0.16 Billion55.88%
2012 -NZ$97.9 Million169.94%
2011 -NZ$36.27 Million-63.44%
2010 -NZ$99.19 Million-7.19%
2009 -NZ$0.11 Billion15.91%
2008 -NZ$92.2 Million83.89%
2007 -NZ$50.14 Million78.1%
2006 -NZ$28.16 Million16%
2005 -NZ$24.27 Million45.24%
2004 -NZ$16.71 Million682.42%
2003 -NZ$2.14 Million1659.12%
2002 -NZ$0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B 3,109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.73 B 1,094.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.55 B 5,860.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.23 B 1,235.08%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-NZ$0.35 Billion-132.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$88.94 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA